News on Amgen
ShareAnalyze the latest news on Amgen, extract the entire dataset or get visualizations.
Related dashboards:
Latest news
Amgen starts two critical late-stage trials for weight loss drug MariTide
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Stocks making the biggest moves premarket: Amgen, Best Buy, Abercrombie & Fitch, Stellantis and more
Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressed
Amgen says no concerns around weight loss drug's bone density data after stock falls
Stocks making the biggest moves midday: Rivian, Cava, Rocket Lab, Amgen and more
Amgen to open new tech and innovation center in Hyderabad by end of 2024
Stocks making the biggest moves premarket: Disney, Airbnb, Rivian, Amgen and more
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Amgen teased trial results for its potential Ozempic competitor -- and the stock surged 13%
Stocks making the biggest moves premarket: Apple, Amgen, Cloudflare and more
Amgen scraps experimental weight loss pill, moves forward with injection
Amgen wants in on the booming weight loss drug market -- and it's taking a different approach
Extract data
Extract all the news on this scope:
Visualize data
Trend on this scope:
Evolution through time
Source analysis:
Distribution of sources in the news
Section analysis:
Distribution of sections in the news
Current sentiment polarity: neutral (0.14)
| neutral | 67% | |
| positive | 25% | |
| negative | 8% |
Sentiment polarity through time
